Publication | Closed Access

Short-term treatments with haloperidol or bromocriptine do not alter the density of the monoamine vesicular transporter in the substantia nigra

Substantia NigraMedicinePsychotropic MedicationNeuropharmacologyMonoamine Vesicular TransporterPharmacotherapyNeurologyExperimental PharmacologyPharmacologyShort-term TreatmentsDrug DiscoveryTranslational Pharmacology